Arginine vasopressin clinical trials

Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR Trial)

This study looks at a new way to reduce the risk of kidney damage after a liver transplant. It compares a medication called arginine-vasopressin (AVP) with a standard treatment, norepinephrine, to see if AVP can better protect your kidneys during and after surgery.